eLife-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2019-11-29 146e4e40m72暂无昵称

请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久

187 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2023-02-27 ms2000000333658765 来自上海

本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水

62 0

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2019-08-26 小高兴

2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。

180 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2022-02-08 bigOne

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：Biomarker
经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。

83 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2020-06-16 ms4608271349787965

审稿速度:1.0
经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的

433 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2018-04-26 storyhare

审稿速度:1.0 | 投稿命中率:5.0
经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。
个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。

659 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2021-12-12 1331f29716m

审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0
偏重的研究方向：代谢
经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。

243 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2022-10-23 slientwo

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：生物学
经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。

56 0

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2022-08-22 ms7000000077155394

2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多

140 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=580680, encodeId=1968580680ed, content=请问这个杂志拒稿快么？临近毕业还是想试一下高分，怕耽误太久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=16365175013, createdName=146e4e40m72暂无昵称, createdTime=Fri Nov 29 00:00:00 CST 2019, time=2019-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116644, encodeId=4c5e2116644a5, content=本来就是先发预印本了。。再不拒稿。。。后面不知道会不会变水, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9acf8521381, createdName=ms2000000333658765, createdTime=Mon Feb 27 09:57:04 CST 2023, time=2023-02-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=575383, encodeId=adde5e538303, content=2019年8月15日投的稿，已经12天了，状态还是subbmitted，有没有大神遇到到这种情况，不是说elife审稿速度快吗？好着急啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58425127264, createdName=小高兴, createdTime=Mon Aug 26 22:49:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191264, encodeId=91d5119126433, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：Biomarker 经验分享：目前杂志只接受预印本。如果初审通过，必须先在预印本发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d03856469, createdName=bigOne, createdTime=Tue Feb 08 23:15:05 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861997, encodeId=706d86199e5b, content=审稿速度:1.0 经验分享：国际顶级期刊，审稿专家和编辑都非常严谨敬业，投稿难度挺大的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce15414064, createdName=ms4608271349787965, createdTime=Tue Jun 16 23:01:04 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555417, encodeId=a3d255541e2e, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：个人感觉 elife 这个杂志投稿难度相当大，我曾经在这个杂志上栽过一次跟头，我们实验室做的关于RLKs参与植物抗逆的研究，投稿 elife 不到二周拒稿，最终文章被另一个高 IF 杂志 molecular cell 接收。 个人感觉说 elife 投稿容易的纯粹是扯淡！在生物学期刊里，molecular cell 的投稿难度相当大，至少远远难于 nature communications 、cell research 之流，而从我们实验室投稿经历来看， elife 投稿难度高于 molecular cell ，因此不难推测出 elife 投稿难度，绝对远远难于 nature communications 、cell research 之流。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=659, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb651930132, createdName=storyhare, createdTime=Thu Apr 26 10:39:00 CST 2018, time=2018-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079177, encodeId=656c10e9177b8, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:3000.0 偏重的研究方向：代谢 经验分享：整个过程很专业化，不拖时间。一个月时间审稿，结束后修改两个月，返修回去一个月接受，感觉很流畅。杂志偏向生物学的整体完整性，比如小鼠的数据比分子的数据要多，对于机制方面要求没有MC要求高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19b12083027, createdName=1331f29716m, createdTime=Sun Dec 12 07:40:58 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095483, encodeId=2bba209548306, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：生物学 经验分享：2013年才有第一个影响因子，老外很喜欢Elife杂志，Plos创始人之一接替之前的主编开始新的一轮改革。现在更喜欢接受新奇且抓人眼球的文章，风格和Plos biology太像了。看中的是文章是否提出新的概念，整体机制看中减少一些，生物学厚重感比EMBO reports差些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Sun Oct 23 07:40:34 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1240235, encodeId=42021240235a0, content=2022未来科学奖的李文辉发的就是这个，这个杂志基本可以看成是open acess的PNAS，水平和投稿难度和PNAS基本差不多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7b18287601, createdName=ms7000000077155394, createdTime=Mon Aug 22 09:37:49 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801583, encodeId=28ca801583ad, content=投稿命中率:25.0 经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c2d2527089, createdName=124f15b3m82暂无昵称, createdTime=Tue Jul 07 09:28:40 CST 2020, time=2020-07-07, status=1, ipAttribution=)]

2020-07-07 124f15b3m82暂无昵称

投稿命中率:25.0
经验分享：各位，initial submission的状态:submitted，check email 需要多久时间呢？

255 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务